Rhythm Pharmaceuticals, Inc. (RYTM)
Last updated: 2026-11-19 02:45:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Rhythm Pharmaceuticals, Inc. (RYTM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $119.14, with a market capitalization of $7.45B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $74.50 to $122.20. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$7.45B | |
$115.72 | |
$121.23 | |
$114.01 | |
$116.61 | |
1.98M | |
1.06M | |
-- | |
$122.20 | |
$74.50 | |
0.02% | |
2026-09-30 |
Rhythm Pharmaceuticals, Inc. (RYTM) Latest Closing Stock Price
Rhythm Pharmaceuticals, Inc. (RYTM) last closed at $119.14 as of 2026-11-19 01:00:00, up 2.14% ($2.49) from the previous close of $116.61.
During the latest regular trading session, RYTM traded between $114.01 and $121.23, with a volume of 1.98M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Why Is RYTM Stock Up Today?
RYTM is up 2.14% as of the last close.
Rhythm Pharmaceuticals shares are trading higher. Traders allege that Eli Lilly submitted an offer to acquire the company for $150 per share.
Rhythm Pharmaceuticals, Inc. (RYTM) 7-Day Stock Price Change
Over the past seven days, Rhythm Pharmaceuticals, Inc. (RYTM) moved from $113.94 to $119.14, representing a gain of 4.57% ($5.20).
The stock traded between $104.20 and $121.23 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.20 million shares, down versus the previous seven-day period, indicating lower trading activity.
RYTM 52-Week Price Position
Position in Range: 93.6%
RYTM is currently trading at $119.14, placing it 93.6% of the way from its 52-week low of $74.50 to its 52-week high of $122.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Rhythm Pharmaceuticals, Inc. (RYTM)?
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
Rhythm Pharmaceuticals, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 414 |
| Exchange | NASDAQ |
| Company Website |
RYTM News
Latest news related to Rhythm Pharmaceuticals, Inc. and RYTM stock.
- Read Full Article
- Read Full Article
Rhythm Pharmaceuticals Shares See Volume; Traders Circulate M&A Rumors At $15/Share
- Read Full Article
Rhythm Pharmaceuticals Says Rare Obesity Drug Delivers Sustained Two-Year BMI Reductions
Rhythm Pharmaceuticals reports two-year Phase 3 setmelanotide data and new expert diagnostic criteria for acquired hypothalamic obesity.
Ways to Trade RYTM at MEXC
How to Buy Rhythm Pharmaceuticals, Inc. (RYTM) Stock on MEXC
Eligible investors can buy real shares of Rhythm Pharmaceuticals, Inc. (RYTM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Rhythm Pharmaceuticals, Inc. (RYTM) stock price today?
2.Is RYTM stock going up or down today?
3.What is RYTM pre-market price?
4.What is RYTM after-hours price?
5.Is RYTM stock trading now?
6.Where does RYTM sit relative to its 52-week high and low?
7.What sector is Rhythm Pharmaceuticals, Inc. in?
8.What is Rhythm Pharmaceuticals, Inc.'s market capitalization and where is it listed?
9.How is RYTM valued in terms of P/E ratio and EPS?
10.Does Rhythm Pharmaceuticals, Inc. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to RYTM, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
RYTM Stock Calculator
Estimate the value between RYTM shares and USD.
RYTM Shares to USD
1.00 RYTM shares = 119.144 USD
Calculations are estimates based on the latest available price and are for reference only.


